English | 繁體

Search in the results

UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
CERS4 predicts positive anti-PD-1 response and promotes immunomodulation through Rhob-mediated suppression of CD8+Tim3+ exhausted T cells in non-small cell lung cancer Journal article
Wang Jian, Li RunZe, Wang WenJun, Pan HuDan, Xie Chun, Yau LeeFong, Wang XingXia, Long WeiLi, Chen RuiHong, Liang TuLiang, Ma LinRui, Li JiaXin, Huang JuMin, Wu QiBiao, Liu Liang, He JianXing, Leung Elaine Lai Han. CERS4 predicts positive anti-PD-1 response and promotes immunomodulation through Rhob-mediated suppression of CD8+Tim3+ exhausted T cells in non-small cell lung cancer[J]. Pharmacological Research, 2023, 194, 106850.
Authors:  Wang Jian;  Li RunZe;  Wang WenJun;  Pan HuDan;  Xie Chun; et al.
Favorite | TC[WOS]:7 TC[Scopus]:6  IF:9.1/9.0 | Submit date：2023/08/03
Cd8++++ Tim-3++++ t Cell  Cers4  Icis  Nsclc  Rhob  Sphingolipid Metabolism  
The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance Review article
2022
Authors:  Run-Ze Li;  Xuan-Run Wang;  Jian Wang;  Chun Xie;  Xing-Xia Wang; et al.
Favorite | TC[WOS]:33 TC[Scopus]:35  IF:3.5/4.0 | Submit date：2023/01/30
Anticancer  Cancer  Enzymes  Immunotherapy  Sphingolipid Metabolism  
To be a medicine or a toxin? This is a question – a sphingolipid story Journal article
Zhang, H.. To be a medicine or a toxin? This is a question – a sphingolipid story[J]. Clinical Pharmacology and Toxicology Research, 2017, 8-8.
Authors:  Zhang, H.
Favorite |